(C94.7) Other specified leukaemias

More details coming soon

Icon
120 090 in individuals diagnosis other specified leukaemias confirmed
Icon
16 667 deaths with diagnosis other specified leukaemias
Icon
14% mortality rate associated with the disease other specified leukaemias

Diagnosis other specified leukaemias is diagnosed Men are 17.58% more likely than Women

70 602

Men receive the diagnosis other specified leukaemias

8 490 (12.0 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
49 488

Women receive the diagnosis other specified leukaemias

8 177 (16.5 %)

Died from this diagnosis.

Risk Group for the Disease other specified leukaemias - Men aged 60-64 and Women aged 70-74

Icon
In Men diagnosis is most often set at age 0-14, 20-95+
Icon
Less common in men the disease occurs at Age 15-19Less common in women the disease occurs at Age 5-9, 15-19, 35-39, 95+
Icon
In Women diagnosis is most often set at age 0-5, 10-14, 20-34, 40-94

Disease Features other specified leukaemias

Icon
Absence or low individual and public risk
Icon

Other specified leukaemias - what does this mean

Other specified leukaemias are a group of diseases in which the body produces too many immature white blood cells. these leukaemias are caused by genetic mutations or acquired mutations in the dna of the white blood cells, which leads to the production of abnormal cells that cannot function properly. these cells accumulate in the bone marrow and other organs, leading to a decrease in healthy white blood cells, anemia, and other symptoms.

What happens during the disease - other specified leukaemias

Other specified leukaemias are a group of rare leukaemias caused by an abnormal proliferation of white blood cells that results from a genetic mutation. the mutation causes the white blood cells to grow and divide rapidly, leading to an accumulation of immature cells in the blood and bone marrow. this accumulation of cells can interfere with the production of healthy red blood cells, leading to anemia, fatigue, and other symptoms.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete blood count
  • Bone marrow aspiration and biopsy
  • Cytogenetic and molecular genetic testing
  • Flow cytometry
  • Immunohistochemistry
  • Cytochemical stains
  • Lymph node biopsy
  • Serum protein electrophoresis

Treatment and Medical Assistance

Main goal of the treatment: To provide effective treatment for Other specified leukaemias.
  • Conducting regular physical examinations and blood tests to monitor the disease.
  • Prescribing medication to reduce the number of leukaemia cells in the blood.
  • Administering chemotherapy to kill the leukaemia cells.
  • Prescribing radiation therapy to kill the leukaemia cells.
  • Performing bone marrow or stem cell transplants to replace damaged bone marrow.
  • Administering targeted therapy to block the signals that allow leukaemia cells to grow.
  • Prescribing immunotherapy to boost the immune system's ability to fight the leukaemia cells.
Icon
14 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Other specified leukaemias - Prevention

The best way to prevent other specified leukaemias is to reduce exposure to environmental risk factors such as certain chemical agents and radiation, maintain a healthy lifestyle, and get regular medical check-ups. this includes avoiding smoking, eating a balanced diet, exercising regularly, and limiting alcohol consumption. additionally, it is important to get vaccinated against certain infections such as human t-cell lymphotropic virus (htlv-1) and hepatitis b.